Edition:
United Kingdom

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

67.44USD
16 Oct 2018
Change (% chg)

$1.67 (+2.54%)
Prev Close
$65.77
Open
$66.62
Day's High
$67.90
Day's Low
$65.33
Volume
533,261
Avg. Vol
724,791
52-wk High
$81.22
52-wk Low
$37.39

Select another date:

Wed, Aug 22 2018

Exact Sciences surges after marketing deal with Pfizer for cancer test

Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer.

UPDATE 1-Exact Sciences surges after marketing deal with Pfizer for cancer test

Aug 22 Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer.

Exact Sciences signs marketing deal with Pfizer for cancer test

Aug 22 Exact Sciences Corp said on Wednesday Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer, in a bid to boost sales of the product.

UPDATE 1-American Cancer Society recommends earlier colorectal cancer screening

May 30 The American Cancer Society on Wednesday recommended that people at average risk of colorectal cancer start regular screening at the age of 45 rather than at 50, at a time when studies show a rise in cases of the disease among younger individuals.

BRIEF-Exact Sciences Says CEO Kevin T. Conroy's 2017 Total Compensation Was $13.3 Million

* EXACT SCIENCES CORP SAYS CEO KEVIN T. CONROY'S 2017 TOTAL COMPENSATION WAS $13.3 MILLION – SEC FILING Source : https://bit.ly/2w2gEbC Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Exact Sciences reports Q1 Loss Per Share of $0.33

* Q1 EARNINGS PER SHARE VIEW $-0.37 -- THOMSON REUTERS I/B/E/S

Select another date: